INNOVUS PHARMACEUTICALS, INC. (OTCMKTS:INNV) Files An 8-K Other EventsItem 8.01 – Other Events
On August 10, 2018, the Company issued a press release announcing that it had entered into a purchase agreement with Showcase, a Canadian company for the purchase of its product Apeaz® for sale in its 110 stores in the U.S. and Canada.
The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 — Financial Statements and Exhibits
Press release issued August 10, 2018.
INNOVUS PHARMACEUTICALS, INC. ExhibitEX-99.1 2 ex99-1.htm ADDITIONAL EXHIBITS Exhibit 99.1 Exhibit 99.1 Innovus Pharma Signs Purchase Agreement with “Showcase – The Home of the Hottest Trends” to Sell the Company’s Apeaz® Cream for the Relief of Arthritis Pain in its 110 “Showcase” Retail Stores in the United States and Canada Apeaz® is the Fifth Company Product to Be Sold in Retails Stores in the U.S. and Canada San Diego,…To view the full exhibit click
About INNOVUS PHARMACEUTICALS, INC. (OTCMKTS:INNV)
Innovus Pharmaceuticals, Inc. is a pharmaceutical company engaged in the commercialization, licensing, and development of non-prescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases. The Company markets approximately five products in the United States and six in a range of countries around the world through its commercial partners. It has commercial agreements in over 60 countries around the world through its commercial partners. Its marketed products include Zestra, EjectDelay, Sensum+, Zestra Glide, Vesele and Androferti. In addition, the Company has a pipeline of over three additional products, including FlutiCare Over-The-Counter (OTC) for Allergic Rhinitis; Urocis XR, an extended release of Vaccinium Marcocarpon (cranberry), and AndroVit, a supplement to support overall prostate and male sexual health, which is marketed in Europe.